Literature DB >> 11302900

Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study.

G Rebello1, N Hallam, G Smart, D Farquharson, J McCafferty.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11302900      PMCID: PMC30583          DOI: 10.1136/bmj.322.7291.893

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  A systematic review of the role of human papillomavirus testing within a cervical screening programme.

Authors:  J Cuzick; P Sasieni; P Davies; J Adams; C Normand; A Frater; M van Ballegooijen; E van den Akker
Journal:  Health Technol Assess       Date:  1999       Impact factor: 4.014

2.  Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.

Authors: 
Journal:  J Natl Cancer Inst       Date:  2000-03-01       Impact factor: 13.506

3.  Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses.

Authors:  W K Kinney; M M Manos; L B Hurley; J E Ransley
Journal:  Obstet Gynecol       Date:  1998-06       Impact factor: 7.661

4.  Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.

Authors:  M M Manos; W K Kinney; L B Hurley; M E Sherman; J Shieh-Ngai; R J Kurman; J E Ransley; B J Fetterman; J S Hartinger; K M McIntosh; G F Pawlick; R A Hiatt
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

5.  HPV testing in primary screening of older women.

Authors:  J Cuzick; E Beverley; L Ho; G Terry; H Sapper; I Mielzynska; A Lorincz; W K Chan; T Krausz; P Soutter
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

  5 in total
  6 in total

1.  HPV testing for clarifying borderline cervical smear results.

Authors:  M M Manos
Journal:  BMJ       Date:  2001-04-14

2.  Human papillomavirus testing. Authors' comments.

Authors:  G Rebello; N Hallam; G Smart; D Farquharson; J McCafferty
Journal:  BMJ       Date:  2001-07-14

3.  Use of HC2 to triage women with borderline and mild dyskaryosis in the UK.

Authors:  M Arbyn; J Roelens; P Martin-Hirsch; S Leeson; N Wentzensen
Journal:  Br J Cancer       Date:  2011-09-27       Impact factor: 7.640

4.  HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study.

Authors:  R S Kelly; J Patnick; H C Kitchener; S M Moss
Journal:  Br J Cancer       Date:  2011-09-06       Impact factor: 7.640

5.  Evaluation of adjunctive HPV testing by Hybrid Capture II in women with minor cytological abnormalities for the diagnosis of CIN2/3 and cost comparison with colposcopy.

Authors:  Andrea Guyot; Shakir Karim; May S Kyi; John Fox
Journal:  BMC Infect Dis       Date:  2003-09-25       Impact factor: 3.090

6.  Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate.

Authors:  Marc Arbyn; Pierre Martin-Hirsch; Frank Buntinx; Marc Van Ranst; Evangelos Paraskevaidis; Joakim Dillner
Journal:  J Cell Mol Med       Date:  2009-01-23       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.